Authors: Bae S, Kwon J, Lee SB, Jang IJ, Yu KS, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 15, Pp 5099-5108 (2021)

Subject Terms: crossover design, healthy subjects, intragastric ph monitoring, randomized controlled study, Therapeutics. Pharmacology, RM1-950, proton pump inhibitors

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::7d92a5a60f5f850ace31cdc00b9bcb4e
https://www.dovepress.com/comparative-pharmacokineticspharmacodynamics-of-fixed-dose-combination-peer-reviewed-fulltext-article-DDDT

Authors: Hwang S, Lee DY, Cho JY, Chung JY, Jang IJ, Yu KS, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 15, Pp 2375-2384 (2021)

Subject Terms: pharmacogenomics, phase 1 study, selective serotonin reuptake inhibitors, clinical pharmacology, Therapeutics. Pharmacology, RM1-950

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::b3907c13b8248a4ab47a091cc88f7b61
https://www.dovepress.com/pharmacokinetics-tolerability-and-pharmacogenetics-of-da-8031-after-mu-peer-reviewed-fulltext-article-DDDT

Authors: Jeon I, Oh J, Kwon YK, Yoon SH, Cho JY, Jang IJ, Yu KS, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 15, Pp 1735-1747 (2021)

Subject Terms: pharmacodynamics, Therapeutics. Pharmacology, RM1-950, biosimilar, pharmacokinetics, darbepoetin alfa

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::8ad3d12655d43d7d7a1a934fe74e86c7
https://www.dovepress.com/comparison-of-pharmacokinetic-pharmacodynamic-and-tolerability-profile-peer-reviewed-fulltext-article-DDDT

Authors: Yang E, Yoo H, Jang IJ, Yu KS, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 15, Pp 651-658 (2021)

Subject Terms: bioequivalence, lcsh:Therapeutics. Pharmacology, dyslipidemia, lcsh:RM1-950, dpp-4 inhibitor, statin, type 2 diabetes

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::0f32c5ad9a95a5e46286d173a9c51017
https://www.dovepress.com/pharmacokinetic-and-pharmacodynamic-comparison-of-two-formulations-of--peer-reviewed-article-DDDT

Authors: Hwang I, Kim Y, Yoo H, Jang IJ, Yu KS, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 14, Pp 4493-4502 (2020)

Subject Terms: drug interaction, lcsh:Therapeutics. Pharmacology, evogliptin, lcsh:RM1-950, pharmacodynamics, pioglitazone, pharmacokinetics

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::be0142c36c425b85e2e24e7a589742f9
https://www.dovepress.com/pharmacokineticpharmacodynamic-interaction-between-evogliptin-and-piog-peer-reviewed-article-DDDT

Authors: Han, SM, Park, J, Lee, JH, Lee, SS, Kim, H, Han, H, Kim, Y, Yi, S, Cho, JY, Jang, IJ, Lee, MG

Source: Clinical Pharmacology & Therapeutics. Mar 01, 2017 101(3):396-405

Availability: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=fulltext&D=ovft&CSC=Y&NEWS=N&SEARCH=%2210.1002/cpt.532%22.di

Authors: Yoon DY, Park SI, Jung JA, Kim YI, Jang IJ, Chung JY

Source: Drug Design, Development and Therapy, Vol Volume 14, Pp 661-668 (2020)

Subject Terms: fixed-dose combination, bioequivalence, hypertension, lcsh:Therapeutics. Pharmacology, dyslipidemia, lcsh:RM1-950, loose combination, pharmacokinetics

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::5a4c8a0cad384b195ff0b5fe4b14001d
https://www.dovepress.com/comparison-of-pharmacokinetics-of-a-fixed-dose-combination-of-amlodipi-peer-reviewed-article-DDDT

Authors: Kim E, Park KR, Jang IJ, Yu KS, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 13, Pp 3879-3885 (2019)

Subject Terms: lcsh:Therapeutics. Pharmacology, dyslipidemia, lcsh:RM1-950, dpp-4 inhibitor, statin, type 2 diabetes, pharmacokinetics

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::35df3c8d83c8af6298648e94e49d9704
https://www.dovepress.com/a-fixed-dose-combination-of-gemigliptin-and-rosuvastatin-exhibits-simi-peer-reviewed-article-DDDT

Authors: Choi Y, Lee S, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol Volume 12, Pp 2301-2309 (2018)

Subject Terms: HMG-CoA inhibitor, Angiotensin receptor blocker (ARB), lcsh:Therapeutics. Pharmacology, Drug interaction, Fimasartan, lcsh:RM1-950, Atorvastatin, Pharmacokinetics

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::8a610425b223b2db2675fbfec3b7767d
https://www.dovepress.com/pharmacokinetic-interaction-between-fimasartan-and-atorvastatin-in-hea-peer-reviewed-article-DDDT

Authors: Choi Y, Yoon S, Matsumoto K, Ohta Y, Lee S, Yu KS, Jang IJ

Source: Drug Design, Development and Therapy, Vol Volume 12, Pp 1045-1051 (2018)

Subject Terms: hepatitis C virus, lcsh:Therapeutics. Pharmacology, lcsh:RM1-950, pharmacokinetics, Telaprevir

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::a6df2e5b7d886583ff5f74ace2ea283a
https://www.dovepress.com/pharmacokinetic-characteristics-of-telaprevir-in-healthy-korean-male-s-peer-reviewed-article-DDDT

Authors: Kim YK, Shin KH, Alderman J, Yu KS, Jang IJ, Lee S

Source: Drug Design, Development and Therapy, Vol Volume 12, Pp 331-337 (2018)

Subject Terms: lcsh:Therapeutics. Pharmacology, pharmacokinetics (PK), lcsh:RM1-950, migraine, eletriptan hydrobromide, Korean subjects

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::b3e3d4b6e164bffa32b00c2c127b3fff
https://www.dovepress.com/pharmacokinetics-and-tolerability-of-eletriptan-hydrobromide-in-health-peer-reviewed-article-DDDT

Authors: Kim S, Lee S, Cho JY, Yoon SH, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol Volume 11, Pp 3187-3195 (2017)

Subject Terms: lcsh:Therapeutics. Pharmacology, First-in-human, lcsh:RM1-950, NQO1, Pharmacokinetics, Phase 1, Pharmacogenomics

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::417a587670e2f6af7f8c34c0098a58be
https://www.dovepress.com/pharmacokinetics-and-tolerability-of-mb12066-a-beta-lapachone-derivati-peer-reviewed-article-DDDT

Authors: H. M. Byun, Sumin Yoon, Kyung Sang Yu, Jang Ij, Howard Lee, Jai Young Cho, Sojeong Yi, S. B. Jang

Source: Alimentary Pharmacology & Therapeutics. 46:337-346

Subject Terms: Adult, Male, Pharmacology, Placebo, 030226 pharmacology & pharmacy, Esomeprazole, Gastric Acid, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Pharmacokinetics, medicine, Humans, Pharmacology (medical), Cross-Over Studies, Hepatology, business.industry, Gastroenterology, Hydrogen-Ion Concentration, Anti-Ulcer Agents, Crossover study, Regimen, Tolerability, Pharmacodynamics, Gastric acid, 030211 gastroenterology & hepatology, business, medicine.drug

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc0db33e2145981c88c0465e989e7cf7
https://doi.org/10.1111/apt.14148

Authors: Shin D, Lee S, Yi S, Yoon SH, Cho JY, Bahng MY, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol Volume11, Pp 713-723 (2017)

Subject Terms: selective serotonin reuptake inhibitor, lcsh:Therapeutics. Pharmacology, first-in-human, DA-8031, lcsh:RM1-950, pharmacokinetics, premature ejaculation

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::d3b69a38f79e837154a76c338932f3e9
https://www.dovepress.com/pharmacokinetics-and-tolerability-of-da-8031-a-novel-selective-seroton-peer-reviewed-article-DDDT

Authors: Jung Sang Lee, Sumin Yoon, K S Lim, Sojeong Yi, Seung-Hyun Kim, Jai Young Cho, Jang Ij, Bo-Hyung Kim, Jae Yong Chung, Kwang-Hee Shin, Kyung Sang Yu, Hae-Sim Park, Seung Hwan Lee, Sang Chun Ji

Source: Clinical and Translational Science. 10:163-171

Subject Terms: 0301 basic medicine, Drug, Liver injury, Azelaic acid, business.industry, General Neuroscience, media_common.quotation_subject, Urinary system, General Medicine, Lymphocyte proliferation, Amoxicillin, Pharmacology, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine, Metabolome, 030211 gastroenterology & hepatology, General Pharmacology, Toxicology and Pharmaceutics, business, media_common, medicine.drug

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_________::db13c1abb6564681cf4d6ccb0eaf854a
https://doi.org/10.1111/cts.12425

Authors: Choi Y, Lee S, Cho SM, Kang WH, Nam KY, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol Volume 10, Pp 3021-3028 (2016)

Subject Terms: lcsh:Therapeutics. Pharmacology, Drug Development, lcsh:RM1-950, Comparative Pharmacokinetics, Amlodipine, Losartan

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::0022a427f503337a47dfb8a15d0022b7
https://www.dovepress.com/comparisons-of-the-pharmacokinetics-and-tolerability-of-fixed-dose-com-peer-reviewed-article-DDDT

Authors: Rhee SJ, Lee S, Yoon SH, Cho JY, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 1411-1418 (2016)

Subject Terms: fixed-dose combination, bioequivalence, metformin XR, lcsh:Therapeutics. Pharmacology, evogliptin, lcsh:RM1-950, food effect, pharmacokinetics

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::d6a2c497b130d8f4e0beb3f059c35c8c
https://www.dovepress.com/pharmacokinetics-of-the-evogliptinmetformin-extended-release-51000-mg--peer-reviewed-article-DDDT

Authors: Gu N, Cho JY, Shin KH, Jang IJ, Rhee MY

Source: Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 1525-1531 (2016)

Subject Terms: aldosterone, lcsh:Therapeutics. Pharmacology, lcsh:RM1-950, renin activity, fimasartan, pharmacokinetics, sodium

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::5d0be1c4a562848009126068c34571de
https://www.dovepress.com/the-influence-of-dietary-sodium-content-on-the-pharmacokinetics-and-ph-peer-reviewed-article-DDDT

Authors: Yoon S, Shin D, Lee H, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 5033-5049 (2015)

Subject Terms: lcsh:Therapeutics. Pharmacology, lcsh:RM1-950

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::a01fa780ab729459df0f078744e645b3
http://www.dovepress.com/pharmacokinetics-pharmacodynamics-andnbsptolerability-of-lc350189-a-no-peer-reviewed-article-DDDT

Authors: Chung H, Lee H, Han H, An H, Lim KS, Lee YJ, Cho JY, Yoon SH, Jang IJ, Yu KS

Source: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 2609-2616 (2015)

Subject Terms: lcsh:Therapeutics. Pharmacology, lcsh:RM1-950

Access URL: https://explore.openaire.eu/search/publication?articleId=doajarticles::0c8207a0171bedc39bc4afe6ed7e6e20
http://www.dovepress.com/a-pharmacokinetic-comparison-of-two-voriconazole-formulations-and-the--peer-reviewed-article-DDDT